Education
About Us
Working with TipRanks
Follow Us
ONO Pharmaceutical Co (OPHLF)
:OPHLF
RESEARCH TOOLSreports
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of $5.56B. The enterprise value is $755.47B.
Market Cap$5.56B
Enterprise Value$755.47B
Share Statistics
ONO Pharmaceutical Co has 498.69M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498.69M
Owened by Insiders
Owened by Instutions
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee$125,694,004.672
Profits Per Employee$27,792,369.582
Employee Count3,853
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is ―. ONO Pharmaceutical Co’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of $484.30B and earned $107.08B in profits. Earnings per share was $202.00.
Revenue$484.30B
Gross Profit$365.06B
Operating Income$121.70B
Pretax Income$119.08B
Net Income$107.08B
EBITDA137.19B
Earnings Per Share (EPS)202.00
Cash Flow
In the last 12 months, operating cash flow was $108.66B and capital expenditures -$14.74B, giving a free cash flow of $93.92B billion.
Operating Cash Flow$108.66B
Free Cash Flow$93.92B
Free Cash Flow per Share$188.33
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of $0.28, resulting in a dividend yield of 4.61%
Dividend Per Share$0.28
Dividend Yield4.61%
Payout Ratio23.83%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-24.34%
50-Day Moving Average10.36
200-Day Moving Average11.91
Relative Strength Index (RSI)29.10
Average Volume (3m)849.00
Important Dates
ONO Pharmaceutical Co upcoming earnings date is May 8, 2025, TBA.
Last Earnings DateFeb 3, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
ONO Pharmaceutical Co as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid $23.91B in taxes.
Income Tax$23.91B
Effective Tax Rate―
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
ONO Pharmaceutical Co has $177.04B in cash and marketable securities with $152.87B in debt, giving a net cash position of -$24.17B billion.
Cash & Marketable Securities$177.04B
Total Debt$152.87B
Net Cash-$24.17B
Net Cash Per Share-$48.47
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for ONO Pharmaceutical Co is $9.76, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$9.76
Price Target Upside-13.24%
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast